Clew snaps up key health briefs

Clew Communications, the specialist healthcare shop run by former Guardian journalist Chris Mihill, has scooped three accounts - including one with Novartis for its new osteoporosis drug Aclasta.

The agency will handle pre-launch and launch activity for the drug, which is set to launch later this year. The drug aims to treat brittle bones with a once-a-year treatment. It is taken via an annual 15-minute infusion and Clew will concentrate on promoting it as reducing ­patients' pill burden.

He added that osteoporosis tends to affect older people, particularly women.

The Aclasta brief was won following a competitive pitch. There was no incumbent.

Clew has also landed an account with Cambrian Healthcare, which manages private mental hospitals. The hospitals are, in effect, care homes which take in people who have had mental health problems and have been in long-stay accommodation.

Comms will focus on reg­ional press to allay fears in specific regions as well as on health trade press and health pages in the nationals.

Clew will also carry out more general media relations work on the desirability of more places being made available for this sort of psychiatric rehabilitation.

Clew's third new account is with Cambrian Education, which oversees residential schools for children with aut­ism. The benefits of residential care will be flagged up to education and society jou­r­­­nalists on nationals.

Mihill said the agency would present residential care for autistic children as value for public money. ‘Nowhere else provides the care these children need.'

In a separate development, Mihill has moved from MD to chairman while co-founder Mary Hicks, formerly a dir­ector, takes over his post.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in